Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...
Researchers at University of Tsukuba have demonstrated that tomato mutants lacking the SlIAA9 gene, an auxin signaling ...
A novel imaging method captures ultrafast events with unprecedented detail by combining laser encoding and AI reconstruction. Researchers have introduced a new imaging method that reveals far more ...
Dawe, PhD, as Scientific Advisor, Neuropharmacology & Translational Neuroscience, and Tomi K. Sawyer, PhD, as Strategic ...
This article examines target-based vs phenotypic screening, comparing mechanisms, advantages, limitations, and use cases to ...
Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, ...
As EPR programs expand across the U.S., brands face overlapping deadlines and evolving rules. This article breaks down what’s ...
Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...
A new report published this week outlines further details of Apple’s plan to combat the crease. According to TrendForce, two ...
Apple is believed to be using a number of different approaches in order to minimize the visibility of the crease, and supply-chain market intelligence firm TrendForce has outlined to us the elements ...
The East Asian Subtropical Westerly Jet (EASWJ) and the East Asian Summer Monsoon (EASM) are two pivotal components of the ...
HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the preclinical poster presentation titled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results